Ranbaxy Rides On Fda Prescription
Ranbaxy Laboratories (RLL) edged up on Tuesday following reports that the company has received the US Food and Drug Administration
WebinarsNew
Deep DiveNew
Explore Business Standard
WebinarsNew
Deep DiveNew
Explore Business Standard
Ranbaxy Laboratories (RLL) edged up on Tuesday following reports that the company has received the US Food and Drug Administration
First Published: Apr 02 2003 | 12:00 AM IST